PI-2301, copolymer

A board to discuss future MS therapies in early stage (Phase I or II) trials.

PI-2301, copolymer

Postby RuSmolikova » Mon Mar 15, 2010 12:34 am

I am seeking all information about the CO-200-201 trial that is supposed to start in Europe this year (PI-2301 copolymer, Peptimmune Incl. USA). There is no information on clinicaltrials.com.
Does anybody have details about the trial? (how is it designed, what phase, the main goal, age of participants, type of MS, inclusion and exclusion criteria, primary and secondary outcomes, etc...)
Thanks in advance!
User avatar
RuSmolikova
Family Elder
 
Posts: 161
Joined: Thu Nov 01, 2007 4:00 pm
Location: Prague

Advertisement

Postby patientx » Fri Mar 19, 2010 4:37 am

I did some searching, and couldn't come up with much. You may already know this information, but here's some links that mention their phase Ib study that apparently established safety, and their plans to do a phase II trial:

http://www.peptimmune.com/research_deve ... is/pi_2301

http://www.medicalnewstoday.com/articles/161838.php

Also, Squiffy had posted this:

http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1397

Actually, if you want to get more information about their upcoming trials, maybe the best thing to do is call the company.
User avatar
patientx
Family Elder
 
Posts: 1068
Joined: Wed Sep 10, 2008 3:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post
  • PI 2301
    by bromley » Wed Oct 03, 2007 6:25 am
    1 Replies
    1373 Views
    Last post by NHE View the latest post
    Thu Oct 04, 2007 5:17 am
  • PI-2301
    by bromley » Fri Jan 18, 2008 1:57 pm
    0 Replies
    1220 Views
    Last post by bromley View the latest post
    Fri Jan 18, 2008 1:57 pm
  • PI-2301
    by scoobyjude » Sat Mar 22, 2008 9:22 pm
    1 Replies
    1753 Views
    Last post by cheerleader View the latest post
    Tue Jun 17, 2008 1:42 pm

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service